FONAR Co. (NASDAQ:FONR - Get Free Report)'s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $14.42 and traded as high as $14.64. FONAR shares last traded at $14.52, with a volume of 17,307 shares trading hands.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded FONAR from a "buy" rating to a "strong-buy" rating in a report on Monday, May 19th.
Get Our Latest Stock Analysis on FONAR
FONAR Trading Up 0.3%
The firm has a 50-day simple moving average of $12.97 and a two-hundred day simple moving average of $14.42. The company has a market capitalization of $89.94 million, a price-to-earnings ratio of 12.61 and a beta of 1.00.
FONAR (NASDAQ:FONR - Get Free Report) last issued its quarterly earnings data on Thursday, May 15th. The medical equipment provider reported $0.37 EPS for the quarter. FONAR had a return on equity of 4.94% and a net margin of 7.68%.
Hedge Funds Weigh In On FONAR
Several hedge funds and other institutional investors have recently modified their holdings of FONR. Empowered Funds LLC raised its position in FONAR by 5.1% in the 4th quarter. Empowered Funds LLC now owns 19,635 shares of the medical equipment provider's stock valued at $297,000 after purchasing an additional 945 shares during the last quarter. Bridgeway Capital Management LLC grew its stake in shares of FONAR by 1.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 80,035 shares of the medical equipment provider's stock worth $1,212,000 after purchasing an additional 945 shares during the period. JPMorgan Chase & Co. grew its stake in shares of FONAR by 148.3% during the third quarter. JPMorgan Chase & Co. now owns 3,012 shares of the medical equipment provider's stock worth $49,000 after purchasing an additional 1,799 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of FONAR by 0.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock worth $5,703,000 after purchasing an additional 2,149 shares during the period. Finally, Money Concepts Capital Corp grew its stake in shares of FONAR by 1.2% during the first quarter. Money Concepts Capital Corp now owns 406,296 shares of the medical equipment provider's stock worth $5,692,000 after purchasing an additional 4,719 shares during the period. Institutional investors own 50.64% of the company's stock.
FONAR Company Profile
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
See Also
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
